Allen King

Allen King is the Market Access and HEOR (Health Economics and Outcomes Research) Team Leader for Hemophilia Gene Therapy at Pfizer. He has over 20 years of experience in pricing and market access within the pharmaceutical industry. Based in the Greater Philadelphia area, King has developed a strong background in strategic marketing and business development, particularly in the context of innovative therapies for hemophilia.

His professional profile highlights a commitment to enhancing patient access to therapies through effective market strategies and collaboration with healthcare stakeholders. King's expertise encompasses understanding market dynamics, customer experiences, and competitive landscapes, which are crucial for the successful introduction of new treatments in the healthcare market.1